Vyome owns 70% of Livechain; Board focused on value creation

Vyome Holdings, Inc. (“Vyome”) (Nasdaq: HIND), a clinical-stage healthcare holding company, today announced its Board of Directors has agreed to conduct a full review of strategic alternatives for Livechain Inc. (OTCID: LICH), a company in which Vyome is the controlling shareholder.

“As promised, we are committed to our shareholders and maximizing shareholder value. Most of our shareholders are probably completely unaware that we are a 70% controlling shareholder of LICH; we are keen to explore all ways to create value from this asset. At this point, the Board has not formed an opinion as to the best path for Livechain, but we intend to spend the next month reviewing the costs and benefits of our options, which could include launching a new business, forming a crypto treasury, merging with an existing business, or an outright sale,” said Krishna Gupta, Chairman of Vyome.

“Vyome originally purchased a controlling interest in LICH in 2021 with the intention of potentially listing on the OTC to establish a viable publicly held business. With Vyome now trading on Nasdaq, there is an opportunity to look at other creative options for LICH,” said Venkat Nelabhotla, CEO of Vyome.

About Vyome

Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome’s immediate focus is leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning across the US-India innovation corridor, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety. To learn more, please visit www.vyometx.com

Visit us on social media:

Facebook

X

LinkedIn

Forward-Looking Statements

Certain statements made in this press release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “target,” “believe,” “expect,” “will,” “shall,” “may,” “anticipate,” “estimate,” “would,” “positioned,” “future,” “forecast,” “intend,” “plan,” “project,” “outlook”, and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Vyome’s control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include the risks stated in our filings with the Securities and Exchange Commission., Vyome cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vyome does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250818462628/en/